Cargando…

Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene

BACKGROUND: The objective of this study was to evaluate serum IGF-I levels in postmenopausal women with breast cancer treated primarily with raloxifene. METHODS: Twenty-two postmenopausal patients with operable, stage I or II, estrogen receptor-positive carcinomas participated in this study. Followi...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Silva, Benedito B, Moita, Daniel S, Pires, Cleicilene G, Sousa-Junior, Edílson C, dos Santos, Alesse R, Lopes-Costa, Pedro V
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1945022/ https://www.ncbi.nlm.nih.gov/pubmed/17645796 http://dx.doi.org/10.1186/1477-7800-4-18

Ejemplares similares

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020)

Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women
por: van Essen, Huib W., et al.
Publicado: (2007)

Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer
por: Torrisi, R, et al.
Publicado: (2001)

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
por: Darbà, Josep, et al.
Publicado: (2013)

Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
por: Messalli, Enrico M, et al.
Publicado: (2010)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women
por: Ha, J., et al.
Publicado: (2022)

Quality of life and patient satisfaction with raloxifene/cholecalciferol combination therapy in postmenopausal women
por: Lee, Dong-Yun, et al.
Publicado: (2022)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara, Saeko, et al.
Publicado: (2014)

Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy
por: Mullins, C. Daniel, et al.
Publicado: (2003)

Raloxifene Ameliorates Glucosamine-Induced Insulin Resistance in Ovariectomized Rats
por: Chen, Chung-Hwan, et al.
Publicado: (2021)

Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
por: Dogiparthi, Anuradha, et al.
Publicado: (2010)

Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis
por: Islander, Ulrika, et al.
Publicado: (2011)

A randomized trial of estrogen or raloxifene during postmenopausal weight loss: Adiposity and cardiometabolic outcomes
por: Van Pelt, R.E., et al.
Publicado: (2013)

Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence
por: Chen, Mingsheng, et al.
Publicado: (2016)

The effect of raloxifene on left ventricular hypertrophy in postmenopausal women: A prospective, randomized, and controlled study
por: Bal, Uğur Abbas, et al.
Publicado: (2015)

Raloxifene in Hemodialysis Patients
por: Keller, Frieder
Publicado: (2012)

Oxidative Stress and Raloxifene
por: Akgol, Gurkan, et al.
Publicado: (2012)

Raloxifene/Vitamin D Combination Therapy vs. Raloxifene Monotherapy on Serum 25-Hydroxy-Vitamin D Level among Postmenopausal Women with Osteoporosis or Osteopenia: A Randomized Controlled Trial
por: Lee, You-Bin, et al.
Publicado: (2022)

Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials
por: Lin, Tiao, et al.
Publicado: (2014)

Safety of Raloxifene in Hemodialysis Patients
por: Jacobsen, Didy
Publicado: (2012)

Fractures in women treated with raloxifene or alendronate: a retrospective database analysis
por: Foster, Shonda A, et al.
Publicado: (2013)

Co‐consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants
por: Clarke, John D., et al.
Publicado: (2023)

Is raloxifene associated with lower risk of mortality in postmenopausal women with vertebral fractures after vertebroplasty?: a hospital-based analysis
por: Su, Fu-Mei, et al.
Publicado: (2015)

ODP119 Raloxifene use after denosumab discontinuation partially attenuates bone loss in the lumbar spine in postmenopausal osteoporosis
por: Hone, Namki, et al.
Publicado: (2022)

Effect of Tamoxifen and Raloxifene on the Proliferative Activity of the Breast Epithelium in Premenopausal Women
por: Lucato, Miliana T, et al.
Publicado: (2015)

Hemostatic Effects of Raloxifene in Ovariectomized Rats
por: Alva-Chavarría, Denys, et al.
Publicado: (2023)

Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial
por: Kianimehr, Gilda, et al.
Publicado: (2014)

Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single
por: Shin, Chang Jin, et al.
Publicado: (2016)

Effects of strength training and raloxifene on femoral neck metabolism and microarchitecture of aging female Wistar rats
por: Stringhetta-Garcia, Camila Tami, et al.
Publicado: (2017)

Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection
por: Allegretti, Marcello, et al.
Publicado: (2021)

Raloxifene for older women: a review of the literature
por: Hansdóttir, Helga
Publicado: (2008)

Identification and Characterization of Potential Impurities in Raloxifene Hydrochloride
por: Reddy, Reguri Buchi, et al.
Publicado: (2012)

Effects of Raloxifene on Bone Metabolism in Hemodialysis Patients
por: Iwamoto, Jun
Publicado: (2012)

Significant Effect of Raloxifene on Bone in Hemodialysis Patients
por: Ravn, Pernille
Publicado: (2012)

Antileishmanial Activity of the Estrogen Receptor Modulator Raloxifene
por: Reimão, Juliana Q., et al.
Publicado: (2014)

The Pharmacokinetics of Raloxifene and Its Interaction with Apigenin in Rat
por: Chen, Yan, et al.
Publicado: (2010)

Raloxifene as a treatment option for viral infections
por: Hong, Subin, et al.
Publicado: (2021)

Raloxifene induced keratopathy: A case report
por: Park, Ji Min, et al.
Publicado: (2022)

Influence of CYP19A1 gene expression levels in women with breast cancer: a systematic review of the literature
por: Barros-Oliveira, Maria da Conceição, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b48ni4j1m970euperms3ede87c